Search - tctmd.com

Displaying 681 - 700 of 1203

Sort: Relevancy | Date

Presentation TCT 2014

Mechanisms, Predictors, and Unusual Causes of Early, Late, and Very Late Stent Thrombosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Fernando Alfonso

September 15, 2014

Presentation TCT 2014

Mechanisms, Predictors, and Unusual Causes of In-Stent Restenosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Lisette Okkels Jensen

September 15, 2014

Presentation TCT 2014

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Presentation TCT 2014

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

Presenter: John A. Bittl, Tullio Palmerini, Joo Myung Lee, MD

September 15, 2014

News Conference News TCT 2014

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

September 15, 2014

News Conference News TCT 2014

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

September 15, 2014

News Conference News TCT 2014

Less Mortality with Paclitaxel-Coated Balloon vs. Stent in DES Restenosis

September 15, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Conference News TCT 2014

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

September 15, 2014

News Conference News TCT 2014

COMBO Stent Achieves Neointimal Regression at 24 Months

September 15, 2014

Presentation TCT 2014

Advanced Treatment Options for Recurrent DES Restenosis: From Drugs to Brachytherapy

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Paul S. Teirstein

September 14, 2014

Presentation TCT 2014

Treatment Options for BMS and DES ISR: What Works Best?

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Fernando Alfonso

September 14, 2014

Presentation TCT 2014

Use of OCT to Evaluate Stent Failures (Thrombosis and Restenosis)

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Evelyn S. Regar

September 14, 2014

Presentation TCT 2014

Use of IVUS to Evaluate Stent Failures (Thrombosis and Restenosis)

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Gary S. Mintz

September 14, 2014

Presentation TCT 2014

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Presenter: Gregg W. Stone, Pieter C. Smits, Fernando Alfonso

September 14, 2014

News Conference News TCT 2014

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

September 14, 2014

News Industry News

Randomized Trial of Intravascular Ultrasound-Guided Intervention Demonstrates Improved Outcomes for Patients with Chronic Total Coronary Artery Occlusion

September 14, 2014

News Conference News TCT 2014

OCT STEMI: Imaging-Guided PCI Shows Promise

September 14, 2014

News Industry News

New Study Finds Everolimus-Eluting Stents Provide Superior Clinical Outcomes Compared to Drug-Eluting Balloons in Patients with Drug-Eluting Stent Restenosis

September 14, 2014

News Industry News

New Study Assesses the Utility of Optical Coherence Tomography During Stent Implantation in Primary PCI

September 14, 2014

Advertisement

Mechanisms, Predictors, and Unusual Causes of Early, Late, and Very Late Stent Thrombosis

Mechanisms, Predictors, and Unusual Causes of In-Stent Restenosis

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

Novel Biodegradable Polymer DES Shows Efficacy, Long-term Safety

Marie-Claude Morice, MD, Receives 2014 Master Clinical Operator Award

Less Mortality with Paclitaxel-Coated Balloon vs. Stent in DES Restenosis

Keynote Address Focuses on Newer DES, Problematic Subgroups

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

COMBO Stent Achieves Neointimal Regression at 24 Months

Advanced Treatment Options for Recurrent DES Restenosis: From Drugs to Brachytherapy

Treatment Options for BMS and DES ISR: What Works Best?

Use of OCT to Evaluate Stent Failures (Thrombosis and Restenosis)

Use of IVUS to Evaluate Stent Failures (Thrombosis and Restenosis)

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

RIBS IV: EES Superior to DEB in Patients with In-Stent Restenosis

Randomized Trial of Intravascular Ultrasound-Guided Intervention Demonstrates Improved Outcomes for Patients with Chronic Total Coronary Artery Occlusion

OCT STEMI: Imaging-Guided PCI Shows Promise

New Study Finds Everolimus-Eluting Stents Provide Superior Clinical Outcomes Compared to Drug-Eluting Balloons in Patients with Drug-Eluting Stent Restenosis

New Study Assesses the Utility of Optical Coherence Tomography During Stent Implantation in Primary PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content